Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,302 | 13,713 | 17,400 | 20,554 | 25,678 |
| TOTAL | $10,088 | $14,330 | $17,839 | $22,391 | $26,482 |
| Non-Current Assets | |||||
| PPE Net | 113 | 119 | 57 | 89 | 106 |
| Investments And Advances | 50 | 50 | 50 | 50 | 0 |
| Other Non-Current Assets | 1,419 | 391 | 391 | 0 | 0 |
| TOTAL | $1,582 | $560 | $498 | $138 | $106 |
| Total Assets | $11,670 | $14,889 | $18,337 | $22,529 | $26,588 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,598 | 5,814 | 4,650 | 4,220 | 1,499 |
| Other current liabilities | N/A | N/A | 16 | 301 | 2,849 |
| TOTAL | $5,344 | $6,063 | $4,666 | $4,521 | $4,614 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 531 | 0 | 0 | 0 | 0 |
| TOTAL | $682 | $13 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,026 | $6,077 | $4,666 | $4,521 | $4,614 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,101 | 3,967 | 3,670 | 1,858 | 1,478 |
| Common Shares | 5 | 116 | 80 | 56 | 44 |
| Retained earnings | -208,758 | -186,857 | -163,153 | -136,552 | -112,230 |
| TOTAL | $5,644 | $8,813 | $13,671 | $18,008 | $21,974 |
| Total Liabilities And Equity | $11,670 | $14,889 | $18,337 | $22,529 | $26,588 |